Commentary: Advocacy Perspective

View This PDF

NB: This article is only available as a PDF.

Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.

Advocacy groups like the National Alliance for the Mentally Ill (NAMI) have spent the last 25 years supporting research for a new generation of medications to treat major mental illness, recognizing that the old medications had significant problems with side effects and, in some cases, efficacy. About 10 years ago, new medications—atypical antipsychotics and new antidepressants— began to appear. There was great celebration within NAMI because, for the first time, scientific advances joined with other evidence-based treatments and services to create a system where we could begin to achieve recovery from mental illness.​

J Clin Psychiatry 2003;64(suppl 17):39-40